Bone marrow cell therapy for ischemic heart disease: The never ending story

Circulation Research

Volumn 117, Issue 6, 2015, Pages 490-493

  Pompilio, Giulio ^a,b   Nigro, Patrizia ^a   Bassetti, Beatrice ^a   Capogrossi, Maurizio C ^c  

^a CENTRO CARDIOLOGICO MONZINO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

bone marrow; cardiac cell therapy; Editorial; ischemic heart disease; meta analysis

Indexed keywords

HEPARIN;

ACUTE HEART INFARCTION; ANGIOGENESIS; BONE MARROW CELL THERAPY; BONE MARROW DERIVED MONONUCLEAR CELL; CELL COUNT; CELL THERAPY; CONVALESCENCE; DRUG EFFECT; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HUMAN; ISCHEMIC HEART DISEASE; MULTICENTER STUDY (TOPIC); NONHUMAN; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCAR FORMATION; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; BONE MARROW TRANSPLANTATION; EVIDENCE BASED MEDICINE; MYOCARDIAL ISCHEMIA; TRENDS;

BONE MARROW TRANSPLANTATION; EVIDENCE-BASED MEDICINE; HUMANS; MYOCARDIAL ISCHEMIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84940559737     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.115.307184     Document Type: Review

References (45)

1. Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, Sano M, Takahashi T, Hori S, Abe H, Hata J, Umezawa A, Ogawa S, Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999 103 697 705. doi: 10.1172/JCI5298
2. Dawn B, Abdel-Latif A, Sanganalmath SK, Flaherty MP, Zuba-Surma EK, Cardiac repair with adult bone marrow-derived cells: the clinical evidence. Antioxid Redox Signal 2009 11 1865 1882. doi: 10.1089/ARS.2009.2462
3. Roncalli J, Lemarchand P, Autologous bone marrow cells and ischemic cardiomyopathy. Future Cardiol 2011 7 603 607. doi: 10.2217/fca.11.46
4. Williams AR, Trachtenberg B, Velazquez DL, McNiece I, Altman P, Rouy D, Mendizabal AM, Pattany PM, Lopera GA, Fishman J, Zambrano JP, Heldman AW, Hare JM, Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling. Circ Res 2011 108 792 796. doi: 10.1161/CIRCRESAHA.111.242610
5. Tongers J, Losordo DW, Landmesser U, Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges. Eur Heart J 2011 32 1197 1206. doi: 10.1093/eurheartj/ehr018
6. Sanganalmath SK, Bolli R, Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ Res 2013 113 810 834. doi: 10.1161/CIRCRESAHA.113.300219
7. Tomita S, Li RK, Weisel RD, Mickle DA, Kim EJ, Sakai T, Jia ZQ, Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 1999 100 II247 II256
8. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, Itescu S, Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001 7 430 436. doi: 10.1038/86498
9. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P, Bone marrow cells regenerate infarcted myocardium. Nature 2001 410 701 705. doi: 10.1038/35070587
10. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD, Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002 105 93 98
11. Uemura R, Xu M, Ahmad N, Ashraf M, Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 2006 98 1414 1421. doi: 10.1161/01.RES.0000225952.61196.39
12. Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Tsutsumi Y, Ozono R, Masaki H, Mori Y, Iba O, Tateishi E, Kosaki A, Shintani S, Murohara T, Imaizumi T, Iwasaka T, Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 2001 104 1046 1052
13. Hamano K, Nishida M, Hirata K, Mikamo A, Li TS, Harada M, Miura T, Matsuzaki M, Esato K, Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. Jpn Circ J 2001 65 845 847
14. Karantalis V, Schulman IH, Balkan W, Hare JM, Allogeneic cell therapy: a new paradigm in therapeutics. Circ Res 2015 116 12 15. doi: 10.1161/CIRCRESAHA.114.305495
15. Gyöngyösi M, Wojakowski W, Lemarchand P, ACCRUE Investigators Meta-Analysis of Cell-based Cardiac Studies (ACCRUE) in patients with acute myocardial infarction based on individual patient data. Circ Res 2015 116 1346 1360. doi: 10.1161/CIRCRESAHA.116.304346
16. Liu B, Duan CY, Luo CF, Ou CW, Sun K, Wu ZY, Huang H, Cheng CF, Li YP, Chen MS, Effectiveness and safety of selected bone marrow stem cells on left ventricular function in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials. Int J Cardiol 2014 177 764 770. doi: 10.1016/j.ijcard.2014.11.005
17. Delewi R, Hirsch A, Tijssen JG, Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis. Eur Heart J 2014 35 989 998. doi: 10.1093/eurheartj/eht372
18. Delewi R, Andriessen A, Tijssen JG, Zijlstra F, Piek JJ, Hirsch A, Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a meta-analysis of randomised controlled clinical trials. Heart 2013 99 225 232. doi: 10.1136/heartjnl-2012-302230
19. de Jong R, Houtgraaf JH, Samiei S, Boersma E, Duckers HJ, Intracoronary stem cell infusion after acute myocardial infarction: a meta-analysis and update on clinical trials. Circ Cardiovasc Interv 2014 7 156 167. doi: 10.1161/CIRCINTERVENTIONS.113.001009
20. Chen L, Tong JY, Jin H, Ren XM, Jin H, Wang QJ, Ma GS, Long-term effects of bone marrow-derived cells transplantation in patients with acute myocardial infarction: a meta-analysis. Chin Med J (Engl) 2013 126 353 360
21. Clifford DM, Fisher SA, Brunskill SJ, Doree C, Mathur A, Clarke MJ, Watt SM, Martin-Rendon E, Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: factors that may influence outcomes. PLoS One 2012 7 e37373. doi: 10.1371/journal.pone.0037373
22. Clifford DM, Fisher SA, Brunskill SJ, Doree C, Mathur A, Watt S, Martin-Rendon E, Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev 2012 2 CD006536. doi: 10.1002/14651858.CD006536.pub3
23. Sun L, Zhang T, Lan X, Du G, Effects of stem cell therapy on left ventricular remodeling after acute myocardial infarction: a meta-analysis. Clin Cardiol 2010 33 296 302. doi: 10.1002/clc.20772
24. Singh S, Arora R, Handa K, Khraisat A, Nagajothi N, Molnar J, Khosla S, Stem cells improve left ventricular function in acute myocardial infarction. Clin Cardiol 2009 32 176 180. doi: 10.1002/clc.20470
25. Kang S, Yang YJ, Li CJ, Gao RL, Effects of intracoronary autologous bone marrow cells on left ventricular function in acute myocardial infarction: a systematic review and meta-analysis for randomized controlled trials. Coron Artery Dis 2008 19 327 335. doi: 10.1097/MCA.0b013e328300dbd3
26. Lipinski MJ, Biondi-Zoccai GG, Abbate A, Khianey R, Sheiban I, Bartunek J, Vanderheyden M, Kim HS, Kang HJ, Strauer BE, Vetrovec GW, Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 2007 50 1761 1767. doi: 10.1016/j.jacc.2007.07.041
27. Zhu K, Li J, Wang Y, Luo J, Zhang W, Guo C, Lai H, Wang C, Intramyocardial autologous bone marrow-derived stem cells injection for ischemic heart disease ineligible for revascularization: a systematic review and meta-analysis. Arch Med Res 2015 46 286 295. doi: 10.1016/j.arcmed.2015.06.001
28. Fisher SA, Brunskill SJ, Doree C, Mathur A, Taggart DP, Martin-Rendon E, Stem cell therapy for chronic ischaemic heart disease and congestive heart failure. Cochrane Database Syst Rev 2014 4 CD007888. doi: 10.1002/14651858.CD007888.pub2
29. Fisher SA, Doree C, Mathur A, Martin-Rendon E, Meta-analysis of cell therapy trials for patients with heart failure. Circ Res 2015 116 1361 1377. doi: 10.1161/CIRCRESAHA.116.304386
30. Tian T, Chen B, Xiao Y, Yang K, Zhou X, Intramyocardial autologous bone marrow cell transplantation for ischemic heart disease: a systematic review and meta-analysis of randomized controlled trials. Atherosclerosis 2014 233 485 492. doi: 10.1016/j.atherosclerosis.2014.01.027
31. Li N, Yang YJ, Zhang Q, Jin C, Wang H, Qian HY, Stem cell therapy is a promising tool for refractory angina: a meta-analysis of randomized controlled trials. Can J Cardiol 2013 29 908 914. doi: 10.1016/j.cjca.2012.12.003
32. Fisher SA, Dorée C, Brunskill SJ, Mathur A, Martin-Rendon E, Bone marrow stem cell treatment for ischemic heart disease in patients with no option of revascularization: a systematic review and meta-analysis. PLoS One 2013 8 e64669. doi: 10.1371/journal.pone.0064669
33. Zhao Q, Ye X, Additive value of adult bone-marrow-derived cell transplantation to conventional revascularization in chronic ischemic heart disease: a systemic review and meta-analysis. Expert Opin Biol Ther 2011 11 1569 1579. doi: 10.1517/14712598.2011.616491
34. Nowbar AN, Mielewczik M, Karavassilis M, Dehbi HM, Shun-Shin MJ, Jones S, Howard JP, Cole GD, Francis DP, DAMASCENE writing group Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis. BMJ 2014 348 g2688
35. Jeevanantham V, Butler M, Saad A, Abdel-Latif A, Zuba-Surma EK, Dawn B, Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation 2012 126 551 568. doi: 10.1161/CIRCULATIONAHA.111.086074
36. Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA, Zuba-Surma EK, Al-Mallah M, Dawn B, Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 2007 167 989 997. doi: 10.1001/archinte.167.10.989
37. Afzal MR, Samanta A, Shah ZI, Jeevanantham V, Abdel-Latif A, Zuba-Surma EK, Dawn B, Adult bone marrow cell therapy for ischemic heart disease: evidence and insights from randomized controlled trials. Circ Res 2015 117 558 575. doi: 10.1161/CIRCRESAHA.114.304792
38. Assmus B, Dimmeler S, Zeiher AM, Cardiac cell therapy: lost in meta-analyses. Circ Res 2015 116 1291 1292. doi: 10.1161/CIRCRESAHA.115.306330
39. Francis DP, Mielewczik M, Zargaran D, Cole GD, Autologous bone marrow-derived stem cell therapy in heart disease: discrepancies and contradictions. Int J Cardiol 2013 168 3381 3403. doi: 10.1016/j.ijcard.2013.04.152
40. Yeh ET, Willerson JT, Heparin and bone marrow-derived cell therapy: friend or foe? Circ Res 2012 111 819 820. doi: 10.1161/CIRCRESAHA.112.277517
41. Seeger FH, Rasper T, Fischer A, Muhly-Reinholz M, Hergenreider E, Leistner DM, Sommer K, Manavski Y, Henschler R, Chavakis E, Assmus B, Zeiher AM, Dimmeler S, Heparin disrupts the CXCR4/SDF-1 axis and impairs the functional capacity of bone marrow-derived mononuclear cells used for cardiovascular repair. Circ Res 2012 111 854 862. doi: 10.1161/CIRCRESAHA.112.265678
42. Jones AP, Riley RD, Williamson PR, Whitehead A, Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials. Clin Trials 2009 6 16 27. doi: 10.1177/1740774508100984
43. Kissel CK, Lehmann R, Assmus B, Aicher A, Honold J, Fischer-Rasokat U, Heeschen C, Spyridopoulos I, Dimmeler S, Zeiher AM, Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure. J Am Coll Cardiol 2007 49 2341 2349. doi: 10.1016/j.jacc.2007.01.095
44. Achilli F, Malafronte C, Maggiolini S, STEM-AMI trial Investigators G-CSF treatment for STEMI: final 3-year follow-up of the randomised placebo-controlled STEM-AMI trial. Heart 2014 100 574 581. doi: 10.1136/heartjnl-2013-304955
45. Centola M, Capogrossi MC, Role of G-CSF and GM-CSF therapy in patients with acute myocardial infarction and critical limb ischemia. G Ital Cardiol (Rome) 2014 15 465 474. doi: 10.1714/1640.17970